Rapid development of seizures and PRES in a COVID-19 patient

Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos de Lima, Fabiane, Klein, Sara, El Ammar, Faten, Wu, Shasha, Rose, Sandra, Tao, James X., Issa, Naoum P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931684/
https://www.ncbi.nlm.nih.gov/pubmed/33688630
http://dx.doi.org/10.1016/j.ebr.2021.100436
Descripción
Sumario:Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.

Ejemplares similares